+91 8459596463 (24x7)                                    
Research Reports
CBD (Cannabidiol) market is predicted to grow at nearly 35% percent CAGR during the forecast period 2019 to 2026

Published on- August 01 2019 | Article Id - Pra63498

The worldwide CBD (Cannabidiol) market is predicted to grow at nearly 35 percent CAGR during the forecast period (2019 to 2026). Burgeoning awareness regarding the health benefits of cannabidiol should boost industry returns. Additionally, CBD adoption in pharmaceuticals and for therapeutic purposes is reported to widen the traction of this market in the near future. CBD is slated to experience huge investments from research & development organizations, with its promising results in the field of healthcare & medicine.

Subsequently, productive medical trials and FDA (Food and Drug Administration) sanctions have become paramount to setting the tone for CBD. The revolutionary launch & sanction of EPIDIOLEX cannabidiol has made waves, with the drug being obtained from cannabis sativa. Moreover; this sanction has significantly affected political, financial, & regulatory trends; worldwide. The DEA (Drug Enforcement Administration) is anticipated to alter & reorganize CBD categories from 2019 to 2026. Just last year, INSYS Therapeutics, Inc.; declared the commencement of oral CBD’s 3rd phase clinical trials.

This initiative was undertaken to treat rare cases of infantile spasms and children’s epilepsies. A latest industry report suggests that CBD is a non-psychiatric & non-intoxicative cannabinoid. CBD is not merely free of side effects, but is also quite beneficial to human health. Key shareholders within the Hemp industry have been emphasizing growth, along with product innovations & legislative developments. The IHRs (Industrial Hemp Regulations) cater to areas; such as processing, generation, export, & management across different stages.

The CHTA (Canadian Hemp Trade Alliance) has introduced a scientific & effective substitute, so as to produce authentic & credible results. This option has allowed food subsidiaries to avoid THC testing. Regulatory changes are set to lower the “THC” content of crops and boost the cultivation & sales of CBD. The MCOA (Marijuana Company of America) has collaborated with HoneyB Healthy Living to create a variety of CBD products.